Farzad Nazem
CIK: 0001234663
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAUT
Nautilus Biotechnology, Inc.
Director
Discretionary Trading P&L
Holdings
About NAZEM FARZAD
NAZEM FARZAD (SEC CIK 0001234663) files insider reports with the SEC as Director of Nautilus Biotechnology, Inc. (NAUT).
Signal8 holds 2 ownership filings by NAZEM FARZAD, all Form 4s, filed between Jun 25, 2025 and Jun 22, 2026. Those filings report 2 transactions, from Jun 23, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on NAZEM FARZAD's filings is in SEATTLE, WA.
Recent filings by NAZEM FARZAD
Other insiders filing for Nautilus Biotechnology, Inc. (NAUT)
- Posard Matthew L., Director
- Akinsanya Karen, Director
- McIlwain Matthew S, Director
- Epperly Melissa B,, Director
- AH Equity Partners Bio II, L.L.C., 10% Owner
- Patel Sujal M, CEO, President, and Secretary